The drugs, dabrafenib and trametinib, have been shown to slow or halt the development of paediatric gliomas. Gliomas are the most common type of brain cancer in young people.
The twin treatment can be administered orally as an alternative to chemotherapy, which can delay children's education, restrict socialising and have a lasting emotional impact.